Searchable abstracts of presentations at key conferences in endocrinology

ea0056ep142 | Reproductive Endocrinology | ECE2018

Atypical presentation in a patient with 45,X/46,X,i (X) (q10) Isochromosome Xq in mosaic turner syndrome: a case report

Llanes Mark Ramon Victor , Naranjo May

Isochromosome Mosaic Turner Syndrome (IMTS) is a variant of Turner Syndrome (TS) characterized by cytogenetic profile of 1 or more additional cell lineages aside from 45,X, and the presence of a structurally abnormal X chromosome consisting of either two short or two long arms. IMTS is rare, with only 8–9% prevalence among women with TS based on international studies, and 15% of all TS in the Philippines. A 20 year old female came in due to amenorrhea and alopecia. Physic...

ea0073aep385 | Endocrine-Related Cancer | ECE2021

Ectopic ACTH secretion from a metastatic gastric carcinoma with neuroendocrine component

Montebello Annalisa , Portelli Darryl , Gruppetta Mark

BackgroundEctopic ACTH secretion accounts for 9–18% of ACTH dependent Cushing’s’ syndrome. The most common causes are intrathoracic neuroendocrine tumours. Gastric tumours as a cause of ectopic ACTH secretion are remarkably rare.Case reportA seventy-five-year-old gentleman complained of a four month’s history of epigastric discomfort, anorexia, and weight loss. He was a known diabetic and ...

ea0094cc7 | Section | SFEBES2023

Use of osilodrostat alongside 11C-Methionine PET CT in pituitary-dependent Cushing’s disease may improve radiological detection and lead to better outcomes

Yang Lisa , Gurnell Mark , Wernig Florian

Introduction: Pituitary – dependent Cushing’s disease accounts for approximately 80% of endogenous Cushing’s syndrome but a target lesion is only detectable on MRI in 60% of cases. 11C-methionine PET CT improves detection of indeterminate pituitary lesions. Osilodrostat is a novel steroidogenesis inhibitor which reduces cortisol levels with resultant rise in ACTH and may further enhance the sensitivity of 11C-methionine PET CT in difficult cases...

ea0094p318 | Adrenal and Cardiovascular | SFEBES2023

LH-dependent female testosterone excess persisting after bilateral oophorectomy

Scotucci Jacopo , Gurnell Mark , Powlson Andrew

A 55-year-old post-menopausal female presented with hirsutism and increased libido. Testosterone was elevated at 9.7 (RR <1.8 nmol/l). LH/FSH were appropriate post-menopause (LH 28.8; FSH 54.1U/l). DHEAS, androstenedione and 17-hydroxyprogesterone were unremarkable. GnRH analogue suppression testing (GnST) appropriately suppressed LH/FSH and testosterone (testosterone 0.2 nmol/l), suggesting an LH-dependent source of testosterone. Pelvic MRI suggested a left ovarian tumour...

ea0094p211 | Metabolism, Obesity and Diabetes | SFEBES2023

miR-10b as a novel negative regulator of brown adipogenesis

Kalenderoglou Nikoletta , Younis Awais , Christian Mark

Improved knowledge of adipogenesis is necessary to gain insight into brown and white fat physiology. Interest in adipocyte differentiation has increased markedly over the past few years with emphasis on intersection between microRNAs (miRNAs) and the transcriptional cascade that controls adipogenesis and metabolic dysfunction. The aim of this study is to identify miRNAs that regulate white and brown adipocyte differentiation and define miRNA action in a stem cell model of adip...

ea0094p88 | Neuroendocrinology and Pituitary | SFEBES2023

Macroprolactin: Do we need to repeat its measurement?

Livingston Mark , Laing Ian , Heald Adrian

Macroprolactinaemia, a common phenomenon variably expressed in different assays, influences interpretation of prolactin results, as recognised since 1978. The degree of macroprolactinaemia manifest over time is less well described. We examined how macroprolactin status (based on polyethylene glycol(PEG) precipitation prolactin % recovery) varied over serial measurements in hyperprolactinaemic individuals.Methods: All serum total prolacti...

ea0099ep463 | Pituitary and Neuroendocrinology | ECE2024

A retrospective evaluation of operated non-functional pituitary adenomas over four decades in the maltese population

Mangion Jessica , Vassallo Josanne , Gruppetta Mark

Introduction: Surgery in nonfunctional pituitary adenomas (NFPAs) is usually indicated when there is mass effect or progressive increase in size. Our study aims to analyze NFPAs which were operated until the end of 2023 in a well-defined population.Methods: A retrospective analysis of 128 operated patients with NPFAs, diagnosed at the only central national service hospital in Malta, between January 1980 and December 2023, was performed. Detailed clinical...

ea0065oc1.3 | Metabolism and Obesity | SFEBES2019

Metabolic and functional effects of fatty acid overload on in vitro tissue engineered skeletal muscle

Turner Mark , Rimington Rowan , Martin Neil , Fleming Jacob , Capel Andrew , Hodson Leanne , Lewis Mark

Introduction: Efficient fuel selection between glucose and fatty acids in insulin-sensitive organs is a key feature which determines metabolic health in humans. In skeletal muscle, lipid storage and utilisation can differ between healthy and diseased individuals, however to date there are limited in vitro models to explore this. Therefore, aim of this work was to investigate the effects of nutrition on engineered skeletal muscle health and metabolism.<p class="abs...

ea0034s5.1 | Endocrine consequences of major trauma | SFEBES2014

The immune-endocrine mechanisms of trauma-induced sarcopenia

Hampson Peter , Foster Mark , Taylor Angela , Bentley Conor , Fallowfield Joanne , Midwinter Mark , Arlt Wiebke , Lord Janet

Advances in trauma care have improved survival resulting in more severely injured individuals surviving to enter the trauma care pathway. A significant threat to recovery is now the dysregulated immune response to injury. The hyperinflammatory response of the innate immune system (SIRS), combined with immunoparesis, leads to complications such as multi-organ failure and sepsis. Moreover, recovery from trauma is significantly affected by age, which may be due to changes in the ...

ea0034p3 | Bone | SFEBES2014

The utility of bone turnover markers in Paget's disease of bone

Hannon Mark J , Frizelle Isolda M , Kilbane Mark , McKenna Malachi J

Bone turnover markers (BTMs) may have a role in assessing bone turnover and response to intervention in Paget’s disease. We examined the clinical utility of bone turnover markers at diagnosis through analysis of our database of patients with radiographically confirmed Paget’s disease.We identified 36 patients (20 men); mean age at diagnosis was 71.6 years (range 54–84). Radionuclide imaging identified that 64% had polyostotic disease, with...